Haugen MH, Lingjærde OC, Garred Ø, Hedenfalk I, Loman N, Mills G, Borresen-Dale AL, Naume B, Mælandsmo GM, Engebråten O (2019)
Design of a protein signature predicting response to neo-adjuvant treatment with chemotherapy combined with bevacizumab in breast cancer patients
Ann Oncol, 30 Suppl 3, iii8
DOI 10.1093/annonc/mdz095.022, PubMed 32084915

Zänker KS, Borresen-Dale AL, Huber HP (2016)
Personalized Cancer Care: Risk Prediction, Early Diagnosis, Progression, and Therapy
Biomed Hub, 1 (3), 1-9
DOI 10.1159/000453253, PubMed 31988890

Escala-Garcia M, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Ashworth A, Auer PL, Auvinen P, Beckmann MW, Beesley J, Behrens S, Benitez J, Bermisheva M, Blomqvist C, Blot W, Bogdanova NV, Bojesen SE, Bolla MK, Børresen-Dale AL, Brauch H, Brenner H, Brucker SY, Burwinkel B, Caldas C, Canzian F et al. (2020)
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
Nat Commun, 11 (1), 312
DOI 10.1038/s41467-019-14100-6, PubMed 31949161